Overwhelming majorities of nursing homes are struggling to recruit and retain providers, which has driven huge swathes of the sector to turn away patients, according to a new survey from the American Health Care Association.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
Merck’s high-profile suit Tuesday alleging HHS’ Medicare drug price negotiation policies are coercive and violate drug makers’ First and Fifth Amendment rights says Congress should have instead empowered HHS to either set a maximum amount the government would pay for covered drugs or to use its natural leverage to obtain more favorable drug prices.
HHS Office of Inspector General should target its audits of Medicaid redeterminations, which were on pause during the pandemic, to states that CMS considers high risk for improper Medicaid payments due to eligibility errors, House Energy & Commerce Committee Republicans said in a letter to the government watchdog on Monday (June 5).
Overwhelming majorities of nursing homes are struggling to recruit and retain providers, which has driven huge swathes of the sector to turn away patients, according to a new survey from the American Health Care Association.
FDA has released a new draft guidance for good clinical practice (GCP) when conducting clinical trials, which aims to harmonize the work of an international regulatory group with the agency’s recent work on incorporating new approaches such as decentralized clinical trials, use of wearable devices and artificial intelligence.
Examining conflict of interest rules for advisory committee involvement should be a priority for FDA as the agency looks at revamping its process for gathering outside expertise, two agency center heads said Tuesday (June 6).
The Senate Finance Committee this week will add to the pressure on consolidation and corporate ownership with a hearing set for Thursday (June 8), following the House Energy & Commerce Committee’s passage of a bill including health transparency provisions, as lawmakers are set for a busy week of hearings and floor action following the passage of the debt ceiling legislation last week.
HOT TOPICS
A key digital health lobbying group is calling on Congress to reinstate pandemic billing flexibilities for remote patient monitoring and for CMS to update its approach to artificial intelligence and software as a medical device products by nixing legacy restrictions in Medicare and updating payment mechanisms. |
Courts will be forced to interpret ambiguities in Congress’ landmark drug -pricing law when faced with all-but-certain drug industry suits challenging Medicare drug price negotiation, and lawmakers could avert unnecessary litigation by clarifying “which sections of the statute are judicially reviewable,” the nonpartisan the Congressional Research Service says in a recent report. |
The debt ceiling legislation headed to the president’s desk could stress FDA’s budget, an FDA funding expert warned in a blog post analyzing the high-impact deal. |
As CMS cements its plan to hinge broad coverage of Alzheimer’s anti-amyloid drugs that are fully approved by FDA on patients participating in registries, prominent health policy researchers are warning CMS to tread carefully because the registry requirement could cut off treatments for patients whose providers have limited capacity to collect data and may not be able to safely administer the drugs. |
© 2002-2023. Inside Washington Publishers | Contact Us